Today, U.S. FDA announced the seizures of nearly 2 million units of unauthorized e-cigarette products in Chicago, with an estimated retail value of $33.8 million. fda.gov/news-events/pr…

The FDA can and will do more to stop the illegal importation and distribution of e-cigarette products in the United States. Seizures of illegal e-cigarettes keep products that haven’t been authorized by the FDA out of the United States and out of the hands of youth.

This illegal importation stops today. I personally have observed kids from good families who have become addicted to vaping. They know they’re addicted, they want to stop, and they can’t stop. The FDA will continue to monitor and take necessary actions to prevent these illegal

The FDA Center for Devices and Radiological Health (CDRH) issued General Correspondence Letters to two third-party testing companies in China after discovering data that was falsified or otherwise found to be invalid. fda.gov/news-events/pr…

FDA will be holding the first CEO Forum on its National Listening Tour at FDA Headquarters in White Oak, MD on June 5th. If you are a pharmaceutical or biotech CEO, register today. Early registration is also available for additional locations in June and July.

Ever wondered what keeps the world moving? From your favorite coffee to your latest online order, global supply chains make it all happen — and they’re changing fast. Watch this video as Fulbright-Nehru Research Scholar Chandler Compton and Trade Facilitation Specialist Nikita

FDA Special Agents/U.S. Department of Justice: Law Enforcement Seize Record Amounts of Illegal Drugs, Firearms, and Drug Trafficking Proceeds in International Operation Against Darknet Trafficking of Fentanyl and Opioids; 270 Arrested Across Four Continents justice.gov/opa/pr/law-enf…

Just in – A new paper detailing the history and evolution of FDA’s “Orange Book” publication—the foundational resource for drug approvals, patents, exclusivities, and more. Authors discuss key changes to this essential pharmaceutical industry resource. fdli.org/2025/05/freshl…

FDA's Office of Inspections and Investigations collaborates with trusted regulatory authorities worldwide who share our unwavering commitment to drug safety and quality. bit.ly/4kFsJ9V.

Yesterday, we announced the second annual public meeting to provide educational sessions for stakeholders interested in the approval process for new animal drugs. fda.gov/animal-veterin…

Join us for our next FDA Expert Panel! The panel, comprised of world-renowned experts in their respective fields, will discuss infant formula & issues such as nutrition, reduction of heavy metals, use of seed oils, and added sugars contained in infant formula.

Following a very successful pilot program with FDA’s scientific reviewers, I set an aggressive timeline to scale AI agency-wide by June 30. Today’s rollout of Elsa is ahead of schedule and under budget, thanks to the collaboration of our in-house experts across the centers.

Join us this Thursday for FDA's Cell and Gene Therapy Roundtable. You'll be able to view the livestream from 9am - noon right here on X U.S. FDA.🎥fda.gov/vaccines-blood…

Don’t miss our next FDA Expert Panel livestreaming tomorrow at 10am. The discussion is on infant formula & issues such as nutrition, reduction of heavy metals, use of seed oils, and added sugars. View the livestream here on X or on FDA’s YouTube channel. youtube.com/user/USFoodand…

Today, we issued new educational materials highlighting the agency’s new dietary ingredient notification (NDIN) review process. fda.gov/food/dietary-s…

FDA approves a treatment for ROS1-positive non-small cell lung cancer. fda.gov/drugs/resource…

FDA's Office of Clinical Pharmacology announces the availability of their 2024 annual report. Learn more about OCP’s dedication to excellence and collaboration and its 2025 outlook: fda.gov/media/187053/d…

FDA announces the availability of the 2024 Office of Clinical Pharmacology Annual Report: fda.gov/media/187053/d…

Pleased to be at #DIA2025 today where I shared how we're harnessing the power of AI and big data to revolutionize our approach at the FDA. I'm committed to leading this FDA into a future where regulatory oversight is increasingly data-driven and patient-centric. The potential to

Today, the FDA opened a docket for comments on the agency’s proposed method for prioritizing chemicals in food for post-market assessment. fda.gov/food/hfp-const… The agency is actively working to develop transparent processes for prioritizing chemicals in food for a safety